| 1TO1 | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | 1PE, CA, CIT, NA | enzyme |
| ||||||||||||
| related structures | by homologous chain: 1TMG, 1Y3C | ||||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Binding, proteolytic, and crystallographic analyses of mutations at the protease--inhibitor interface of the subtilisin BPN'/chymotrypsin inhibitor 2 complex., Radisky ES, Kwan G, Karen Lu CJ, Koshland DE Jr, Biochemistry 2004 Nov 2;43(43):13648-56. PMID:15504027 | ||||||||||||||
| Data retrieval |
![]() |
| View 1TO1 in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |